PsychU

Long-Acting Injectable Antipsychotics & The Evolving Healthcare Landscape Post-COVID-19 Pandemic For Patients With Schizophrenia & Bipolar I Disorder
2022-01-21 12:00 - 13:00 (America/New_York) | NY
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
Schizophrenia and Bipolar Disorder have a significant burden that is expected to have escalated due to COVID-19. People with serious mental illness are at increased risk of COVID-19 and have higher rates of hospitalization, morbidity, and mortality. Drs. Correll and Chen will discuss how the pandemic has affected patients with schizophrenia and bipolar disorder, including access to long-acting injectable antipsychotics.

Moderator:
Gina Lau, PharmD
Regional Medical Lead, Otsuka Pharmaceutical Development & Commercialization, Inc.

Featuring

Christoph Correll, MD
Chair of the Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany. Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.

Maxine Chen , PhD
Director, U.S. Medical Affairs, Otsuka Pharmaceutical Development & Commercialization

Gina Lau, PharmD (OPDC)
Regional Medical Lead

Christoph Correll, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Maxine Chen, PhD and Gina Lau, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Home

Events

Virtual Event - The Impact of 2nd Generation Antipsychotic Side Effects on Functioning from a Schizophrenia Patient Perspective: A Global Patient Centered Study
2021-12-15 15:00 - 16:00, 2021-12-15 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in San Diego, Inland Empire, Nevada and Idaho.
In this presentation, the objective is to:

Understand how specific side effects impact daily functioning,
Emotional well-being, and
Overall quality of life (QoL) of patients with schizophrenia from their own perspective.

Featuring

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Proposed Role of Modulating Norepinephrine In Psychiatry Illnesses
2021-12-14 18:30 - 19:30 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in Indiana.

This online session examines the relationship between norepinephrine and psychiatric illnesses by investigating an overlap between monoaminergic pathways and circuitry, and demonstrating how malfunctioning cortical circuits can influence emotions, arousal, and cognition.

Featuring

Chris Bojrab, MD
President of Indiana Health Group, and Chief Medical Officer of M-Life

Alex Matushek, PharmD, MBA
Medical Science Liaison

Speaker Chirs Bojrab, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Alex Matushek, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual and Live Event - 2nd Annual Sozosei Summit to Decriminalize Mental Illness
2021-12-13 13:00 - 2021-12-15 13:00 | Pennsylvania Academy of the Fine Arts (PAFA), 118-128 North Broad Street, Philadelphia, PA, 19102, United States
Home

Events

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
The Sozosei Foundation, a philanthropic arm of Otsuka, has officially opened registration for the 2021 2nd Annual Sozosei Summit to Decriminalize Mental Illness. The Summit will be held from December 13-15, 2021 in Philadelphia, PA at the Pennsylvania Academy of the Fine Arts (PAFA). Portions of the Summit will also be live streamed for those who cannot attend in person.

The Summit is a global event that brings together experts, thought-leaders, people with lived experience, medical professionals, lawyers, judges, advocates, artists, and funders to collaborate, create, and explore pathways to decriminalize mental illness with a particular focus on 988, the new national mental health crisis telephone line, due to go live in July 2022.

Due to the ongoing pandemic, rigorous health and safety protocols will be followed for each day of the Summit. There is no cost to attend the 2021 Summit. Registration is open at www.sozoseisummit.org.

Themes of the 2021 Summit include:

LEARNING FROM THE PAST
Monday, December 13, 1 pm – 5 pm ET
A day dedicated to learning from history including an engaging – and often untold – history of 911, legacies of racism and discrimination in crisis response and care, and how the knowledge of these histories empowers us to build a more equitable and accessible crisis care continuum

ADDRESSING THE PRESENT
Tuesday, December 14, 8 am – 5 pm ET
A full day of collaboration and the latest updates on 988 implementation across the nation, in select states and cities as well as PechaKucha presentations highlighting innovative practices to decriminalize mental illness.

DESIGNING FOR THE FUTURE
Wednesday, December 15, 9 am – 1 pm ET
Using the tools of design and future-back thinking to develop and test new ideas and solutions to build an ideal future where 988 and crisis care is abundant and equitable.

As of October 21, 2021, featured Speakers, Panelists, and Moderators include: Victor Armstrong; Dr. Margie Balfour; Melissa M. Beck, Esq.; Dr. Jill Bowen; William H. Carson, MD; Dr. Taleed El-Sabawi, Ph.D.; Laura Evans; Allison Farrell; Sarah Stein Greenberg; Taun Hall; Dr. David Henderson; Dr. Thomas R. Insel; Angela Kimball; Sheriff Leon Lott; Dr. Benjamin F. Miller; Keris Myrick; Dr. Rebecca Neusteter; Joseph Pyle, MA; Dr. Eric Rafla-Yuan; Dr. Kenneth M. Rogers, MD; Dr. Karen A. Scott, MD, MPH; Dr. Sosunmolu Shoyinka; Joan Taglieri; Dr. Anitra Warrior; and Major Maria D. Yturria.

Please visit www.sozoseisummit.org for complete details including health and safety protocols and lodging information.

Registration

The 2nd Annual Sozosei Summit to Decriminalize Mental Illness is a Virtual and Live Event. There are 200 seats available, however, portions of the Summit will also be live streamed for those who cannot attend in person.

Register Now

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Do Inflammation and Metabolic Disturbances Metastasize to the Brain? Implications for Disease Modeling and Novel Approaches in Psychiatry
2021-12-09 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in Alabama, Florida, Georgia, and South Carolina.
In this presentation, the objectives are to:

Describe the importance of cognitive symptoms as psychiatric targets
Review immune and metabolic systems associated with cognitive deficits and mood disorders
Discuss innovative approaches that may target these systems

Featuring

Samuel Shillcutt, PhD
Professor Emeritus, Mercer University School of Medicine, Department of Psychiatry

Walter Lawhorn, PharmD (OPDC)
Regional Medical Lead

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

Speaker Samuel Shillcutt, PhD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Walter Lawhorn, PharmD and Rachel Self, PhD, MS are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Live Event - Hormones and Depression: What We Know and What is on the Horizon
2021-12-08 19:00 - 21:00 | J. Gilbert’s Wood-Fired Steaks & Seafood, 8901 Metcalf Avenue, Overland Park, KS, 66212, United States
Home

Events

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Live Event for PsychU Members in Overland Park, Kansas.

It is an exciting time for the field of psychiatry and general neuroscience. In the past few decades, there has been an increased understanding of the varied pathological processes leading to the manifestation of mental health disorders.

In this presentation, Rachel Dalthorp, MD, MHSA, will cover evidence demonstrating that gender and reproductive hormones influence nearly all levels of the brain from development and structure to neurocircuit systems and function, including the response to stress. The goal of this talk is to discuss the influence of ovarian hormones, specifically, estradiol, on brain function in women with mood disorders.

Featuring

Steven Stoner, PharmD
Associate Dean for Student Affairs/Clinical Professor, University of Missouri-Kansas City School of Pharmacy

Laura Anguiano, PhD (OPDC)
Senior Clinical & Scientific Liaison

Speaker Steven Stoner, PharmD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Laura Anguiano, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients.
NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

First Episode Psychosis: Focus On US Hispanic Population
2021-12-08 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics

This presentation will review concepts of First Episode Psychosis (FEP) and Coordinated Specialty Care (CSC) while focusing on the cultural considerations for treatment, outcomes, and research for the US Hispanic FEP patient population.

Mauricio Tohen, MD, DrPH, MBA, is University Distinguished Professor and Chairman of the Department of Psychiatry & Behavioural Sciences at the University of New Mexico HSC in Albuquerque NM, USA. In 2014 Dr Tohen was recognized in Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. He is one of 100 scientists worldwide recognized in the Psychiatry/Psychology category. Dr Tohen has published over 350 publications, and has over 20,000 scientific citations. In 2016 the International Society for Bipolar Disorders awarded him the Mogens Schou award for Education and Teaching. In 2017, Dr Tohen was recognized by Expertscape as having the top 0.12% expertise in bipolar disorder worldwide based on citations of published articles between 2007-2017.

Stephen Murray, MBA, PharmD, is a Regional Medical Lead within Field Medical Affairs at Otsuka America Pharmaceutical.

Featuring

Mauricio Tohen, MD, DrPH, MBA
Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico

Stephen Murray, PharmD, MBA (OPDC)
Regional Medical Lead

Dr. Mauricio Tohen is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Dr. Stephen Murray is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Proposed Roles of Modulating Norepinephrine in Psychiatric Illnesses
2021-12-07 13:00 - 14:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This online session examines the relationship between norepinephrine and psychiatric illnesses by investigating an overlap between monoaminergic pathways and circuitry, and demonstrating how malfunctioning cortical circuits can influence emotions, arousal, and cognition.

Featuring

Miranda Fisher, PhD
Medical Science Liaison

Simon Kim, PharmD
Medical Science Liaison

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Speakers Miranda Fisher, Phd; Simon Kim, PharmD; and Dennis Sholler, Phd are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

From Doubt to Dedication: How Provider Perspectives Changed Regarding Long-Acting Injectables

Interview February 5, 2025

These on-demand recordings feature firsthand insights from Stephanie Stecker, PMHNP-BC, and Jessica Bettinger, PMHNP-BC, who share their own journeys from initial resistance to becoming advocates of LAI use for appropriate…

Targeted Interventions May Improve Treatment Adherence In Individuals Living With Schizophrenia

Article October 14, 2024

The identification of the patient’s individual needs and perceptions of their own illness may be a key factor in determining an appropriate intervention to maximize treatment adherence in individuals living…

Multiple States Easing Formulary Restrictions On Antipsychotics

Article July 24, 2024

Nevada can now be added to the growing list of states that have enacted legislation to exempt antipsychotics from step therapy (ST) and prior authorization (PA) protocols. The legislation (Nevada…

Shared Decision Making & Patient Empowerment In The Digital Age: A Conversation Between A Clinician & Patient Advocate (2-Part Series) Patient Engagement Through Technology – Part 2
2021-11-30 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
Digital health technology can be used in a variety of ways to empower patients. Shared decision making is one patient engagement strategy that may be enhanced using digital tools. In this 2-part webinar series, Dr. Adam Kaplin, MD and Kathy Day, MPA, BA, AA, will discuss the potential benefits of shared decision making from the perspective of a clinician and patient advocate. They will also discuss how technology may augment this process and explore how digital tools may improve patient engagement and empowerment in additional ways.

Watch Part 1: Shared Decision Making & The Use Of Digital Tools

Featuring

Adam Kaplin, MD, PhD
Chief Scientific Officer, MyMD Pharmaceuticals

Kathy Day, MPA, BA, AA
Caregiver & Mental Health Advocate in Sacramento, CA; Former Member, Sacramento County Mental Health Board, Active in legislative reform at local and federal levels

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.21.00713

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Suicide Awareness & Prevention 2025

Infographic September 10, 2025

Download Infographic

2025 Mental Health America May Mental Health Action Guide

Downloadable Resource May 30, 2025

Mental Health America founded Mental Health Month in 1949 and has led the effort every May to promote mental wellness nationwide. Learn how to take action to improve your personal…

Rural Minds – Mental Health in Rural America, Jeff Winton

Podcast Episode July 24, 2024

Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on mental health in rural America with special guest, Jeff Winton (Founder of Rural Minds). During this episode, Jeff…

Virtual Event - Exploring Wellness Strategies In Mental Health
2021-11-23 15:00 - 16:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in San Diego, Inland Empire, Nevada, and Idaho.
In this presentation, the objectives are to:

Review the immune system and understand how it affects physical and mental health
Share wellness tips to improve physical and mental health
Explore ways to practice wellness

Featuring

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Exploring Wellness Strategies In Mental Health
2021-11-23 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in San Diego, Inland Empire, Nevada, and Idaho
In this presentation, the objectives are to:

Review the immune system and understand how it affects physical and mental health
Share wellness tips to improve physical and mental health
Explore ways to practice wellness

Featuring

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Shared Decision Making & Patient Empowerment In The Digital Age: A Conversation Between A Clinician & Patient Advocate (2-Part Series) Shared Decision Making & The Use Of Digital Tools - Part 1
2021-11-18 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
Digital health technology can be used in a variety of ways to empower patients. Shared decision making is one patient engagement strategy that may be enhanced using digital tools.

In this 2-part webinar series, Dr. Adam Kaplin, MD and Kathy Day, MPA, BA, AA, will discuss the potential benefits of shared decision making from the perspective of a clinician and patient advocate. They will also discuss how technology may augment this process and explore how digital tools may improve patient engagement and empowerment in additional ways.

Register here for
Part 2: Patient Engagement Through Technology on November 30th at 12:00 pm ET

Featuring

Kathy Day, MPA, BA, AA
Caregiver & Mental Health Advocate in Sacramento, CA; Former Member, Sacramento County Mental Health Board, Active in legislative reform at local and federal levels

Adam Kaplin, MD, PhD
Chief Scientific Officer, MyMD Pharmaceuticals

Speakers are paid employees and/or consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.21.00713

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Monoamine Theory in Depression: Implications for Disease and Treatment
2021-11-17 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in DC, Maryland, North Carolina, South Carolina, and Virginia.

In this virtual learning event, learn about the foundational aspects of the monoamine theory for depression. Follow along as the presenters describe the neurobiological pathways of specific monoamines and their potential roles in emotional behaviors. After a discussion on the monoamine imbalance theory, the current treatment paradigms and neurological theories behind those paradigms will be discussed.

Featuring

Miranda Fisher, PhD
Medical Science Liaison

Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Speakers Miranda Fisher, PhD; Dennis Sholler, PhD; and Amica Simmons-Yon, PharmD, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Mixicity In Depression
2021-11-16 15:00 - 16:00, 2021-11-16 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in San Diego, Inland Empire, Nevada, and Idaho.

This presentation will highlight the mixed states in depression. The symptoms of mixed features, clinical relevance, and impact on treatment outcomes will be discussed.

Featuring

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison

Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Viruses, Vaccines, and Long-Term Consequences: Panel Perspectives
2021-11-16 13:00 - 14:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
SARS-CoV-2 has impacted our health, wealth, and lives on a global scale, the extent to which will not be fully appreciated for years to come. As we re-establish ourselves after more than a year of uncertainty, risk, and restrictions, new challenges and a growing appreciation of the potential long-term consequences of this pandemic are emerging.
Join us for this virtual learning event featuring a panel of esteemed experts as they share perspectives on various aspects of our lives that have been significantly altered due to the global pandemic. Dr. Gary Pattee will be joined by Dr. Gaurava Agarwal, psychiatrist & Director of Physician Well-Being for Northwestern, Kathy Day, caregiver & patient advocate, and Dr. Mojgan Makki, child, adolescent & adult psychiatrist, to discuss critical topics related our world after COVID. This insightful dialogue will include a discussion of the emotional phases of a disaster, a stress continuum model, the impact of COVID on mood & mental health, social isolation & loneliness, as well as provide reasons for hope and sources of resilience.

Featuring

Gaurava Agarwal, MD
Chief wellness executive, Northwestern Medicine
Director of Faculty Wellness, Northwestern University

Kathy Day, MPA, BA, AA
Caregiver & Mental Health Advocate in Sacramento, CA; Former Member, Sacramento County Mental Health Board, Active in legislative reform at local and federal levels

Mojgan Makki, MD​, DFAACAP
Child, Adolescent, and Adult Psychiatry Private Practice, Chicago & Northbrook, IL; Solutions Northshore IOP (Intensive Outpatient Program); Psychiatric School Consultant, multiple locations, Illinois; Distinguished Fellow AACAP

Gary Pattee, MD
Clinical Neurologist, Neurology Associates, P.C.

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

Gaurava Agarwal, MD; Kathy Day, MPA, BA, AA; Mojgan Makki, MD, DFAACAP; and Gary Pattee, MD are paid consultants of of Otsuka Pharmaceutical Development & Commercialization, Inc.
Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Suicide Awareness, Assessment, and Prevention Strategies
2021-11-15 17:30 - 18:30 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
In this presentation, the objectives are to:

Review common terminology used in suicidology
Elucidate statistics associated with suicide globally and in the United States
Discuss the possible relationship between suicide and psychiatric illnesses: major depressive disorder (MDD), bipolar disorder, and schizophrenia
Highlight various suicide assessment tools
Present current research on the neurobiology of suicide
Provide suicide prevention resources and insight into ongoing research

Featuring

Jonathan Singer, PhD, LCSW
Esteemed author and scholar, with expertise in suicide prevention and social worker. He serves as Professor at Loyola University’s School of Social Work, is an emeritus president of the Association of Suicidology, founder & host of the Social Work podcast, as well as PsychU speaker & collaborator.

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

Speaker Jonathan Singer, PhD, LCSW is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Youth Suicide Prevention – Jonathan Singer

Podcast October 12, 2021

Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Aneta Fornal, PharmD as they spill the tea about this week’s hot topic on the mission and insights around…

Suicide & Black Americans: Statistics, Faith, & Contextual Competence

On-Demand Webinar September 10, 2021

Mental health challenges exist across racial/ethnic and cultural lines, impacting individuals from all walks of life. Unfortunately, these challenges impact communities disproportionally.

For Better Or Worse? Bridging The Care Continuum For Mental Health Services In Our New Reality

On-Demand Webinar July 22, 2020

Navigating the health care system, particularly mental health services, is a daunting task during “normal” times. Facing the fluidity and uncertainty of a global pandemic presents many new unique challenges…

Suicide Awareness & Prevention Infographic

Infographic September 23, 2021

If you or someone you know is in crisis, please contact the Suicide Prevention Hotline / Lifeline at 1-800-273-TALK (8255),or text the Crisis Text Line at 741-741 Download Infographic

Virtual Event - The Evolving Psychopharmacology of Major Depressive Disorder
2021-11-11 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in Georgia.

In this presentation, the objectives are to:

Provide a brief overview of depression prevalence and current standard treatments
Review the monoamine hypothesis of depression
Discuss alternative hypotheses of depression
Highlight potential new therapeutic intervention targets

Featuring

Samuel Shillcutt, PhD
Professor Emeritus, Mercer University School of Medicine, Department of Psychiatry

Walter Lawhorn, PharmD (OPDC)
Regional Medical Lead

Speaker Samuel Shillcutt, Phd is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Walter Lawhorn, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Implementing Technology Into the Management of Patients With Mental Health Disorder
2021-11-10 18:00 - 19:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics

This is a Virtual Event for PsychU members in Kentucky, West Virginia, and Indiana.

In this presentation, the objectives are to:

Review current digital health developments in psychiatry and areas in which technology can be used in clinical practice
Consider advantages and challenges of using digital tools in mental health care
Discuss approaches and challenges to implementation and adoption of digital technology in the mental health clinic

Featuring

Evelyn Parrish, PhD, PMHNP-BC, FAANP
Psychiatric Nurse Practitioner, Access Wellness Group; Associate Professor, University of Kentucky College of Nursing

Chip Meyer, PhD (OPDC)
Sr. Clinical & Scientific Liaison

Speaker Evelyn Parrish, PhD, PMHNP-BC, FAANP is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Chip Meyer, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)

On-Demand Webinar December 3, 2025

In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.

Myths & Misconceptions: Bipolar Disorder

Podcast November 10, 2025

Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.

Understanding the Complexity of Attention-Deficit Hyperactivity Disorder

On-Demand Webinar October 16, 2025

Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…

Virtual Event - Viruses, Vaccines, and Long-Term Consequences: Perspectives on SARS-CoV-2 ‘Mythbusters’ Edition
2021-11-10 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
SARS-CoV-2 has impacted our health, wealth, and lives on a global scale, the extent to which will not be fully appreciated for years to come. As we begin to re-establish ourselves after more than a year of uncertainty, risk, and restrictions, many questions have been answered, yet many questions remain regarding this novel coronavirus and its potential long-term consequences to our society.

In this virtual learning event, Drs. Jacquelyn Canning and Gary Pattee dispel some of the most prevalent and persistent myths surrounding the novel coronavirus, viral infection, viral variants, vaccines, and potential consequences of vaccination for the PsychU community. They will reflect on how our understanding of SARS-CoV-2 has evolved since 2019 and review some of the frequent falsehoods surrounding vaccination for COVID. Join us for this lively discussion and share some of your thoughts or experiences as we have all navigated through this global pandemic.

Featuring

Gary Pattee, MD
Clinical Neurologist, Neurology Associates, P.C.

Jacquelyn Canning, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison

Speaker Gary Pattee, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jacquelyn Canning, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

Viruses, Vaccines, & Long-Term Consequences: An Update On SARS-CoV-2

Interview November 3, 2021

SARS-CoV-2 has impacted our health, wealth, and lives on a global scale, the extent to which will not be fully appreciated for years to come. As we begin to re-establish…

Virtual Event - Viruses, Vaccines, and Long-Term Consequences: An Update on SARS-CoV-2
2021-11-03 12:00 - 13:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
SARS-CoV-2 has impacted our health, wealth, and lives on a global scale, the extent to which will not be fully appreciated for years to come. As we begin to re-establish ourselves after more than a year of uncertainty, risk, and restrictions, many questions have been answered, yet many questions remain regarding this novel coronavirus and its potential long-term consequences to our society.

In this virtual learning event, Dr. Rachel Self shares perspectives on what we now know with respect to the virus, viral variants, differential presentation of infection, vaccines, and inflammation with Dr. Gary Pattee, clinical neurologist and assistant professor at University of Nebraska Medical Center. They will reflect on scientific advances in understanding the virus, its mutations, and vaccine development, as well as the potential long-term impact of SARS-CoV-2 as neurological, psychiatric, and other health-related consequences of this novel coronavirus begin to unfold. Resources for the most up to date science on the virus and available vaccines will be discussed for health care providers, their patients, and communities.

Click here to Register for Part II of the Viruses, Vaccines, & Long-Term Consequences event series.

Featuring

Gary Pattee, MD
Clinical Neurologist, Neurology Associates, P.C.

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

Speaker Gary Pattee, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

8% Of Those Who Had Mild COVID-19 Developed No Detectable Antibodies

Article June 1, 2020

In a study of 175 people in China who recovered from COVID-19 (SARS-CoV-2 coronavirus) after experiencing mild symptoms, 8% developed no detectable antibodies in their plasma. Currently, researchers believe that…

Virtual Event - Antipsychotic Treatment Options in Schizophrenia
2021-11-02 15:00 - 16:00 | NY
Home

Events

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, as well as compare evidence supporting oral and long-acting injectable antipsychotics. Lastly, the speakers will explore potential communication strategies for clinicians to assess patient adherence and discuss alternative interventions.

Featuring

Martin Guerrero, MD, JD
Forensic and Geriatric Psychiatrist, El Paso, Texas

Jessie Chambers, PhD
Medical Science Liaison

Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Username or Email Address

Password

Remember Me

Join Event Registration Full

Related Resources

From Doubt to Dedication: How Provider Perspectives Changed Regarding Long-Acting Injectables

Interview February 5, 2025

These on-demand recordings feature firsthand insights from Stephanie Stecker, PMHNP-BC, and Jessica Bettinger, PMHNP-BC, who share their own journeys from initial resistance to becoming advocates of LAI use for appropriate…

Targeted Interventions May Improve Treatment Adherence In Individuals Living With Schizophrenia

Article October 14, 2024

The identification of the patient’s individual needs and perceptions of their own illness may be a key factor in determining an appropriate intervention to maximize treatment adherence in individuals living…

Multiple States Easing Formulary Restrictions On Antipsychotics

Article July 24, 2024

Nevada can now be added to the growing list of states that have enacted legislation to exempt antipsychotics from step therapy (ST) and prior authorization (PA) protocols. The legislation (Nevada…

Neurocircuitry Of Depression
2021-10-27 12:00 - 13:00 | NY
Home

Events

Neurocircuitry Of Depression

During this webinar our speakers will begin with a brief overview of the history of neurocircuitry therapeutics. They will then introduce the core brain networks, and the current state of the hypothesized neurocircuitry dysfunction in depression. Speakers will also discuss the effects of neuromodulation techniques and traditional pharmaceutical and nonpharmaceutical treatments on neurocircuitry. Lastly, the speakers will provide insights on the future of precision psychiatry.

Featuring

Shan Siddiqi , MD
Instructor in Psychiatry, Harvard Medical School; Director of Psychiatric Neuromodulation Research, BWH Center for Brain Circuit Therapeutics; Associated Neuropsychiatrist at Brigham and Women’s Hospital center for Brain/Mind Medicine

Nolan Williams, MD
Assistant Professor, Department of Psychiatry and Behavioral Sciences, Stanford; Director of the Stanford Brain Stimulation Lab

Chloe Liu, PhD (OPDC)
Senior Clinical & Scientific Liaison

Shan Siddiqi & Nolan Williams are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Chloe Liu is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Improving Chronic Disease Control by Bringing Medication Management Services to Patients
2021-10-21 15:00 - 16:00, 2021-10-21 12:00 - 13:00 | NY
Home

Events

Improving Chronic Disease Control by Bringing Medication Management Services to Patients

This is a virtual event for PsychU members in Alaska, California, Colorado, Oregon, Utah, Washington, Wyoming, and New Jersey.

Medication-related problems cost the United States $290 billion per year in avoidable medical spending. In recognizing 2021 National Pharmacy Week, please join Drs. Bryan Archuleta, Simon Kim and Becky Wong for this virtual program where they will discuss the importance of Comprehensive Medication Management (CMM), explore the value of CMM, and describe what a CMM practice looks like and how it is implemented and sustained.

In this presentation, speakers will:

Explain the purpose and components of comprehensive medication management (CMM)Discuss the potential value of CMM and those who may benefit from itExplore what a CMM practice looks like, how CMM is implemented, and how it is sustained

Featuring

Becky Wong, PharmD, MBA
Medical Science Director

Bryan Archuleta, PharmD
Senior Long-Term Care Medical Science Liaison

Simon Kim, PharmD
Medical Science Liaison

Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Mental Health Awareness: A Focus on Suicide and Stigma
2021-10-20 12:00 - 13:00 | NY
Home

Events

Mental Health Awareness: A Focus on Suicide and Stigma

This is a Virtual Event for PsychU members in North Carolina and Virginia.

The presentation aims to raise mental health awareness on suicide. The discussion will review the multifaceted and dynamic factors that contribute to risk and explore prevention strategies focused on reducing stigma and discrimination.

Featuring

Kristen Nagy, PharmD, BCPS, BCPP
Clinical Pharmacy Coordinator-Psychiatry;
Assistant Professor-Sandra and Leon Levine Psychiatry Residency Program,
Atrium Health Behavioral Health, a facility of Carolinas Medical Center Charlotte

Amica Simmons-Yon, PharmD, PhD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Speaker Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Kristen Nagy, PharmD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Virtual Event - Bipolar Disorder: Updates on Research and Clinical Outcomes
2021-10-19 13:00 - 14:00 | NY
Home

Events

Bipolar Disorder: Updates on Research and Clinical Outcomes

This presentation details the multidimensional nature of bipolar disorder and highlights the wide spectrum of associated manic and depressive symptoms. The discussion will review the brain anatomical correlation of symptoms as well as the underlying pathophysiological theories. Furthermore, the impact of residual symptoms on clinical outcomes, on recurrence and cognitive deficits will be explored.

Featuring

Rodrigo Machado-Vieira, MD, PhD, MSc
Professor of Psychiatry & Behavioral Sciences & Director of the Experimental Therapeutics & Molecular Pathophysiology Program (ETP), Faillace Department of Psychiatry & Behavioral Sciences, UTHealth – Houston

Dennis Pabis, PharmD, BCPP (OPDC)
Senior Medical Science Liaison

Speaker Rodrigo Machado-Vieira, MD, PhD, MSc is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Dennis Pabis, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

The Role Of The Pharmacist In The Treatment Of Depression
2021-10-19 12:00 - 13:00 | NY
Home

Events

The Role Of The Pharmacist In The Treatment Of Depression

Depression is one of the most common psychiatric illnesses affecting approximately 8% of American adults in a given year. Despite the high prevalence of depression, it is often not adequately managed. Pharmacists are well placed to have a role in depression management across practice settings, complementing the role of general practitioners and psychiatric providers.

In this webinar, we will discuss the role of the pharmacist in the treatment of depression.

Featuring:

Megan Ehret, PharmD, MS, BCCPPsychU Pharmacist Corner Section Advisor ProfessorDepartment of Pharmacy Practice and ScienceUniversity of Maryland School of Pharmacy

Richard Silvia, PharmD, BCPPProfessorDepartment of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences

Aneta Fornal, PharmDSenior Clinical & Scientific Liaison, Otsuka Field Medical Affairs

Megan Ehret, PharmD, MS, BCCP Dr. Ehret is a graduate of the University of Toledo where she completed her BS and PharmD degrees, and she went on to complete a Psychiatric Pharmacy Residency at the Louis Stokes VAMC, under the direction of Matthew Fuller. She then completed a Psychopharmacology and Pharmacogenomics Fellowship at Nova Southeastern University, under the direction of Gary Levin. After training she received her initial faculty appointment at the University of Connecticut and gained tenure during her stay there. While at the University of Connecticut, Dr. Ehret served as the Vice-Chair of the IRB, Director of Practices for the Center for Correctional Health Networks, and a faculty member for Project: ECHO: Buprenorphine. Currently, her full-time role is a Professor at the University of Maryland School of Pharmacy with a practice site at The University of Maryland Mid Town Campus. Additionally, she also has the privilege of working with the State of Maryland Medicaid Program in evaluating antipsychotic use in the state. She is a Past-President of CPNP and is the current Section Editor for the Pharmacist Corner for PsychU. Dr. Ehret has numerous publications and book chapters describing psychotropic medication adherence and the role of pharmacogenomics in medication selection. Her current interests include psychotropic medication adherence and the advancement of the psychiatric pharmacist in practice.

Richard Silvia, PharmD, BCPP Dr. Silvia earned his Doctor of Pharmacy degree from the University of Rhode Island. Afterwards, he completed a two-year residency/fellowship in psychiatric pharmacy practice at the Institute of Living in Hartford, CT and affiliated with the University of Connecticut School of Pharmacy. He then joined the faculty of MCPHS University in 2001, where he is currently a Professor of Pharmacy Practice. Dr. Silvia maintains a practice site at the Codman Square Health Center, a federally-qualified community health center in Dorchester, MA. He maintains a busy collaborative practice in integrated behavioral health within the primary care clinics of the center. He is Board Certified in Psychiatric Pharmacotherapy (BCPP), and is active in the College of Psychiatric and Neurologic Pharmacists (CPNP) and American College of Clinical Pharmacy (ACCP). His research interests include measuring the effectiveness of clinical pharmacists in novel practice settings and studying the adverse effects observed with psychotropic medications and the appropriate management and treatment of these adverse effects.

Featuring

Megan Ehret, PharmD, MS, BCPP
Professor, Department of Pharmacy Practice & Science, University of Maryland School of Pharmacy

Richard Silvia, PharmD, BCPP
Professor, Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences

Aneta Fornal, PharmD (OPDC)
Medical Science Liaison

Dr. Megan Ehret and Dr. Richard Silvia are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Dr. Aneta Fornal is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Perspectives Of Schizophrenia Treatment Guidelines
2021-10-13 12:00 - 13:00 | NY
Home

Events

Perspectives Of Schizophrenia Treatment Guidelines

Schizophrenia is a challenging diagnosis both domestically and across the world. Various treatment guidelines have been developed by key thought leaders to share perspectives on acute and long-term management of Schizophrenia. Join Jehan Marino, Senior Medical Science Liaison for Otsuka Pharmaceutical Development and Commercialization, as she moderates a robust discussion with Dr. Christoph Correll. Dr. Correll will provide his perspectives of schizophrenia guidelines development, with a focus on key similarities and differences.

Featuring

Christoph Correll, MD
Chair of the Department of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany. Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA.

Jehan Marino, PharmD, BCPP
Medical Science Director

Christoph Correll, MD, is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Jehan Marino, PharmD, BCPP, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.
